Nina Wettschureck and Stefan Offermanns - Physiological Reviews

Local calcium release in dendritic spines required for long-term
synaptic depression. Neuron 28: 233–244, 2000.
453. Miyata M, Kim HT, Hashimoto K, Lee TK, Cho SY, Jiang H, Wu
Y, Jun K, Wu D, Kano M, and Shin HS. Deficient long-term
synaptic depression in the rostral cerebellum correlated with impaired
motor learning in phospholipase C beta4 mutant mice. Eur
J Neurosci 13: 1945–1954, 2001.
454. Mochly-Rosen D, Wu G, Hahn H, Osinska H, Liron T, Lorenz
JN, Yatani A, Robbins J, and Dorn GW II. Cardiotrophic effects
of protein kinase C epsilon: analysis by in vivo modulation of
PKCepsilon translocation. Circ Res 86: 1173–1179, 2000.
455. Moers A, Nieswandt B, Massberg S, Wettschureck N, Gruner
S, Konrad I, Schulte V, Aktas B, Gratacap MP, Simon MI,
Gawaz M, and Offermanns S. G13 is an essential mediator of
platelet activation in hemostasis and thrombosis. Nat Med 9: 1418–
1422, 2003.
456. Moers A, Wettschureck N, Gruner S, Nieswandt B, and Offermanns
S. Unresponsiveness of platelets lacking both G�q and
G�13: implications for collagen-induced platelet activation. J Biol
Chem 279: 45354–45359, 2004.
457. Mombaerts P. Genes and ligands for odorant, vomeronasal and
taste receptors. Nat Rev Neurosci 5: 263–278, 2004.
458. Montaner S, Sodhi A, Molinolo A, Bugge TH, Sawai ET, He Y,
Li Y, Ray PE, and Gutkind JS. Endothelial infection with KSHV
genes in vivo reveals that vGPCR initiates Kaposi’s sarcomagenesis
and can promote the tumorigenic potential of viral latent genes.
Cancer Cell 3: 23–36, 2003.
459. Moxham CM, Hod Y, and Malbon CC. Gi alpha 2 mediates the
inhibitory regulation of adenylylcyclase in vivo: analysis in transgenic
mice with Gi alpha 2 suppressed by inducible antisense RNA.
Dev Genet 14: 266–273, 1993.
460. Moxham CM, Hod Y, and Malbon CC. Induction of G alpha
i2-specific antisense RNA in vivo inhibits neonatal growth. Science
260: 991–995, 1993.
461. Moxham CM and Malbon CC. Insulin action impaired by deficiency
of the G protein subunit G ialpha2. Nature 379: 840–844,
1996.
462. Muca C and Vallar L. Expression of mutationally activated G
alpha s stimulates growth and differentiation of thyroid FRTL5
cells. Oncogene 9: 3647–3653, 1994.
463. Mueller KL, Hoon MA, Erlenbach I, Chandrashekar J, Zuker
CS, and Ryba NJ. The receptors and coding logic for bitter taste.
Nature 434: 225–229, 2005.
464. Munoz JJ and Mackay IR. Production of experimental allergic
encephalomyelitis with the aid of pertussigen in mouse strains
considered genetically resistant. J Neuroimmunol 7: 91–96, 1984.
465. Murakami N, Yokomizo T, Okuno T, and Shimizu T. G2A is a
proton-sensing G protein-coupled receptor antagonized by lysophosphatidylcholine.
J Biol Chem 279: 42484–42491, 2004.
466. Murphy PM. International Union of Pharmacology. XXX. Update
on chemokine receptor nomenclature. Pharmacol Rev 54: 227–229,
2002.
467. Murphy PM, Baggiolini M, Charo IF, Hebert CA, Horuk R,
Matsushima K, Miller LH, Oppenheim JJ, and Power CA.
International union of pharmacology. XXII. Nomenclature for chemokine
receptors. Pharmacol Rev 52: 145–176, 2000.
468. Nagata K, Ye C, Jain M, Milstone DS, Liao R, and Mortensen
RM. Galpha(i2) but not Galpha(i3) is required for muscarinic inhibition
of contractility and calcium currents in adult cardiomyocytes.
Circ Res 87: 903–909, 2000.
469. Nakano K, Suga S, Takeo T, Ogawa Y, Suda T, Kanno T, and
Wakui M. Intracellular Ca(2�) modulation of ATP-sensitive K(�)
channel activity in acetylcholine-induced activation of rat pancreatic
beta-cells. Endocrinology 143: 569–576, 2002.
470. Narumiya S, Sugimoto Y, and Ushikubi F. Prostanoid receptors:
structures, properties, and functions. Physiol Rev 79: 1193–1226,
1999.
471. Nathans J. The evolution and physiology of human color vision:
insights from molecular genetic studies of visual pigments. Neuron
24: 299–312, 1999.
472. Navarro VM, Castellano JM, Fernandez-Fernandez R, Barreiro
ML, Roa J, Sanchez-Criado JE, Aguilar E, Dieguez C,
Pinilla L, and Tena-Sempere M. Developmental and hormonally
CELLULAR FUNCTIONS OF G PROTEINS 1197
Physiol Rev • VOL 85 • OCTOBER 2005 • www.prv.org
regulated messenger ribonucleic acid expression of KiSS-1 and its
putative receptor, GPR54, in rat hypothalamus and potent luteinizing
hormone-releasing activity of KiSS-1 peptide. Endocrinology
145: 4565–4574, 2004.
473. Nebigil CG, Choi DS, Dierich A, Hickel P, Le Meur M, Messaddeq
N, Launay JM, and Maroteaux L. Serotonin 2B receptor
is required for heart development. Proc Natl Acad Sci USA 97:
9508–9513, 2000.
474. Nebigil CG, Jaffre F, Messaddeq N, Hickel P, Monassier L,
Launay JM, and Maroteaux L. Overexpression of the serotonin
5-HT 2B receptor in heart leads to abnormal mitochondrial function
and cardiac hypertrophy. Circulation 107: 3223–3229, 2003.
475. Neer EJ. Heterotrimeric G proteins: organizers of transmembrane
signals. Cell 80: 249–257, 1995.
476. Nel AE, Vandenplas M, Wooten MM, Cooper R, Vandenplas S,
Rheeder A, and Daniels J. Cholera toxin partially inhibits the
T-cell response to phytohaemagglutinin through the ADP-ribosylation
of a 45 kDa membrane protein. Biochem J 256: 383–390, 1988.
477. Nelson G, Hoon MA, Chandrashekar J, Zhang Y, Ryba NJ, and
Zuker CS. Mammalian sweet taste receptors. Cell 106: 381–390,
2001.
478. Nemeth EF and Scarpa A. Rapid mobilization of cellular Ca 2� in
bovine parathyroid cells evoked by extracellular divalent cations.
Evidence for a cell surface calcium receptor. J Biol Chem 262:
5188–5196, 1987.
479. Neptune ER and Bourne HR. Receptors induce chemotaxis by
releasing the betagamma subunit of Gi, not by activating Gq or Gs.
Proc Natl Acad Sci USA 94: 14489–14494, 1997.
480. Neptune ER, Iiri T, and Bourne HR. Galphai is not required for
chemotaxis mediated by Gi-coupled receptors. J Biol Chem 274:
2824–2828, 1999.
481. Neubig RR and Siderovski DP. Regulators of G protein signalling
as new central nervous system drug targets. Nat Rev Drug Discov
1: 187–197, 2002.
482. Neumann J, Schmitz W, Scholz H, von Meyerinck L, Doring V,
and Kalmar P. Increase in myocardial Gi-proteins in heart failure.
Lancet 2: 936–937, 1988.
483. Nieswandt B, Schulte V, Zywietz A, Gratacap MP, and Offermanns
S. Costimulation of Gi- and G12/G13-mediated signaling
pathways induces integrin alpha IIbbeta 3 activation in platelets.
J Biol Chem 277: 39493–39498, 2002.
484. Niggli V. Signaling to migration in neutrophils: importance of
localized pathways. Int J Biochem Cell Biol 35: 1619–1638, 2003.
485. Niu J, Vaiskunaite R, Suzuki N, Kozasa T, Carr DW, Dulin N,
and Voyno-Yasenetskaya TA. Interaction of heterotrimeric G13
protein with an A-kinase-anchoring protein 110 (AKAP110) mediates
cAMP-independent PKA activation. Curr Biol 11: 1686–1690,
2001.
486. Norlin EM, Gussing F, and Berghard A. Vomeronasal phenotype
and behavioral alterations in G alpha i2 mutant mice. Curr Biol 13:
1214–1219, 2003.
487. Oak JN and Van Tol Dopamine HHM. Dopamine system. In:
Encyclopedic Reference of Molecular Pharmacology, edited by Offermanns
S and Rosenthal W. Berlin: Springer, 2004, p. 310–315.
488. Ofer W. G protein regulation of channels. In: Handbook of Cell
Signaling, edited by Bradshaw RA and Dennis EA. Boston, MA:
Academic Press, 2004, p. 667–670.
489. Offermanns S, Hashimoto K, Watanabe M, Sun W, Kurihara
H, Thompson RF, Inoue Y, Kano M, and Simon MI. Impaired
motor coordination and persistent multiple climbing fiber innervation
of cerebellar Purkinje cells in mice lacking Galphaq. Proc Natl
Acad Sci USA 94: 14089–14094, 1997.
490. Offermanns S, Heiler E, Spicher K, and Schultz G. Gq and G11
are concurrently activated by bombesin and vasopressin in Swiss
3T3 cells. FEBS Lett 349: 201–204, 1994.
491. Offermanns S, Hu YH, and Simon MI. Galpha12 and Galpha13
are phosphorylated during platelet activation. J Biol Chem 271:
26044–26048, 1996.
492. Offermanns S, Laugwitz KL, Spicher K, and Schultz G. G
proteins of the G12 family are activated via thromboxane A 2 and
thrombin receptors in human platelets. Proc Natl Acad Sci USA 91:
504–508, 1994.